首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >In reply to 'understanding hypernatremia' and 'thiazides for hypervolemic hypernatremia: A valid therapeutic strategy?'
【24h】

In reply to 'understanding hypernatremia' and 'thiazides for hypervolemic hypernatremia: A valid therapeutic strategy?'

机译:回应“了解高钠血症”和“噻嗪类药物对高容量性高钠血症的治疗方法有效吗?”

获取原文
获取原文并翻译 | 示例
           

摘要

In reply to Dr Kahn, hypervolemic hypernatremia requires disproportionate elevations of total-body sodium content relative to total-body water. Because sodium is largely restricted to the extracellular compartment, water achieves osmotic equilibrium by moving from intracellular to extracellular space. The net result is that the extracellular space expands, total-body water is elevated, and intracellular fluid volume is decreased. These changes are most likely to occur in skeletal muscle, which has limited acute cell volume regulatory mechanisms compared with brain cells. Dr Kahn raises an important observation that in sustained hypervolemic hypernatremia, cell volume regulatory mechanisms may lead to expansion of both intracellular and extracellular fluid volumes. To our knowledge, this hypothesis has not been tested directly.
机译:回答卡恩博士,高容量性高钠血症需要相对于全身水不均衡地增加全身钠含量。由于钠在很大程度上局限于细胞外区室,水通过从细胞内空间移至细胞外空间来实现渗透平衡。最终结果是细胞外空间扩大,体内水升高,细胞内液量减少。这些变化最有可能发生在骨骼肌中,与脑细胞相比,骨骼肌的急性细胞体积调节机制有限。卡恩博士提出了一个重要的观察,即在持续的高血容量性高钠血症中,细胞体积调节机制可能导致细胞内和细胞外液体积的增加。据我们所知,这一假设尚未得到直接检验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号